CanadaBis Capital Inc. produces and sells recreational cannabis and extracts in Canada. Key strengths include a solid gross margin of 47.4%, indicating effective cost management, but concerns arise from negative EBITDA and net margins, reflecting ongoing operational challenges. The current ratio of 1.33 suggests adequate short-term liquidity, though a low quick ratio of 0.27 raises potential cash flow issues. Despite high margins, the low market cap of $2.12M and share price of $0.01 may indicate market skepticism about future profitability.
Loading financial metrics...
Company has $939K in cash but burned $520K last quarter. At this burn rate, only 1.8 quarters of runway remain without additional financing.
Debt of $7.0M is 7.4x the company's cash position of $939K.
Revenue decreased 12.8% year-over-year from $17.3M to $15.1M.
Company went from $215K profit to $-1.3M loss compared to last year.
No significant opportunities identified
Based on current financial metrics
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2026-Q1 (October 31, 2025)